DALLAS, Sept. 22, 2011 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces a stock report featuring biopharmaceutical company Orexigen Therapeutics Inc. (Nasdaq:OREX). The report details the company's most recent developments and news, outlines its financial position and market performance, and includes an easy-to-read stock chart.
Microstockprofit.com is the premiere destination for investment information, making your trading decisions easier than ever. Get the run down on how OREX stacks up against its competitors and check-out the stock's technical data by viewing the free, in-depth report for small-cap stock OREX at: http://www.microstockprofit.com/lp/OREX
This newsletter has been helping traders make great investment decisions on OREX; click here for a 25% discount offer.
In the report, the analyst notes:
"Shares of the San Diego-based drug developer jumped as much as 82% on Wednesday, a day after the company revived its obesity pill, which was previously rejected by the FDA."
"Based on the new feedback from the FDA outlining a clear and feasible path forward for Contrave, OREX has outlined three near-term priorities for the program: finalizing the trial protocol with the agency; re-engaging with parties that expressed interest in partnering the ex-North American markets for Contrave; and implementing the CVOT as soon as it is able."
To read the entire report visit: www.microstockprofit.com/lp/OREX
See what investors are saying about OREX at http://www.stockhideout.com/
Get breaking news on OREX at http://thestockmarketwatch.com
MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. Please visit http://www.microstockprofit.com for more information.
MicroStockProfit.com Disclosure
MicroStockProfit.com is not a registered investment advisor; nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.